跳至主要内容
临床试验/NCT01292629
NCT01292629已完成不适用

Comparison of the HSO iSert 251 Posterior Chamber Aspheric Aphakic Intraocular Lens to Historical / Literature Controls.

Hoya Surgical Optics, Inc.10 个研究点 分布在 1 个国家目标入组 125 人开始时间: 2011年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
125
试验地点
10
主要终点
Visual Acuity

研究概览

简要总结

The purpose of this multi-center clinical trail is to determine the safety and efficacy of the iSert 251 for the correction of aphakia.

详细描述

This study evaluated the safety and effectiveness of the Hoya Surgical Optics iSert Model 251 IOL following primary implantation for the visual correction of aphakia in adults in whom the cataractous lens has been removed by phacoemulsification. Results from this prospective, multicenter clinical trial will be used to support a PMA supplement for the iSert® 251 IOL.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Have been diagnosed with cataract for which phacoemulsification extraction and posterior chamber IOL implantation is indicated
  • Have clear intraocular media
  • Have potential Best Corrected Visual Acuity of 20/40 or better
  • Have preoperative Best Spectacle-Corrected visual acuity of 20/40 or worse

排除标准

  • Have ocular pathology or abnormalities that do or are expected to reduce best corrected visual acuity in the operative eye during the study period
  • Are monocular
  • Have current ocular infection
  • Are taking systemic steroids or other anti-metabolites
  • Have previous retinal detachment in the operative eye or expect to require retinal laser treatment during the course of the study
  • Eligibility criteria not complete. Contact Hoya Surgical Optics, Inc. for more information.

结局指标

主要结局

Visual Acuity

时间窗: 4 to 6 months

BEST Spectacle-Correction (ETDRS) Distance Visual Acuity

次要结局

  • Complications and Adverse Events(4 to 6 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (10)

Loading locations...

相似试验